We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+5.33%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$32.8B
AUM Growth
+$979M
Cap. Flow
-$230M
Cap. Flow %
-0.7%
Top 10 Hldgs %
18.27%
Holding
1,396
New
147
Increased
409
Reduced
509
Closed
201

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$228M
2
INTC icon
Intel
INTC
+$84.1M
3
DIS icon
Walt Disney
DIS
+$74M
4
COP icon
ConocoPhillips
COP
+$47M
5
EOG icon
EOG Resources
EOG
+$44.8M

Sector Composition

Rank Sector Weight
1 Technology 30.23%
2 Healthcare 16.5%
3 Consumer Discretionary 12.62%
4 Financials 10.39%
5 Industrials 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTEX icon
951
Open Text
OTEX
$6.28B
$1.03M ﹤0.01%
21,571
-21,200
-50% -$992K
L icon
952
Loews
L
$24.5B
$1.02M ﹤0.01%
+19,970
New +$973K
AGO icon
953
Assured Guaranty
AGO
$3.73B
$1.01M ﹤0.01%
23,900
-15,000
-39% -$600K
WTM icon
954
White Mountains Insurance
WTM
$5.33B
$1M ﹤0.01%
+900
New +$1.01M
EPR icon
955
EPR Properties
EPR
$4.89B
$1M ﹤0.01%
21,509
-170,900
-89% -$7.21M
CMS icon
956
CMS Energy
CMS
$23.3B
$986K ﹤0.01%
16,100
-14,300
-47% -$822K
NEWT icon
957
NewtekOne
NEWT
$426M
$983K ﹤0.01%
36,800
OPLN
958
Openlane
OPLN
$4.28B
$975K ﹤0.01%
65,000
-247,400
-79% -$4.21M
RCKY icon
959
Rocky Brands
RCKY
$368M
$946K ﹤0.01%
17,500
IOSP icon
960
Innospec
IOSP
$2.09B
$934K ﹤0.01%
9,100
OTLK icon
961
Outlook Therapeutics
OTLK
$187M
$931K ﹤0.01%
+20,700
New +$793K
SPPI
962
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$914K ﹤0.01%
280,400
BRKR icon
963
Bruker
BRKR
$9.4B
$900K ﹤0.01%
14,000
UHS icon
964
Universal Health Services
UHS
$10.2B
$898K ﹤0.01%
6,736
-12,331
-65% -$1.64M
BGS icon
965
B&G Foods
BGS
$303M
$895K ﹤0.01%
28,800
PRDO icon
966
Perdoceo Education
PRDO
$2.17B
$893K ﹤0.01%
74,700
-214,100
-74% -$2.71M
BN icon
967
Brookfield
BN
$102B
$890K ﹤0.01%
37,403
KBH icon
968
KB Home
KBH
$3.5B
$884K ﹤0.01%
19,000
-5,300
-22% -$219K
JOBS
969
DELISTED
51job Inc
JOBS
$876K ﹤0.01%
14,000
-2,000
-13% -$134K
EBS icon
970
Emergent Biosolutions
EBS
$379M
$873K ﹤0.01%
9,400
SR icon
971
Spire
SR
$4.79B
$872K ﹤0.01%
11,800
DHIL
972
DELISTED
Diamond Hill
DHIL
$863K ﹤0.01%
5,530
GL icon
973
Globe Life
GL
$14B
$861K ﹤0.01%
8,908
+39
+0.4% +$3.74K
VIRT icon
974
Virtu Financial
VIRT
$5.04B
$854K ﹤0.01%
27,500
+16,700
+155% +$461K
CRSP icon
975
CRISPR Therapeutics
CRSP
$4.69B
$853K ﹤0.01%
+7,000
New +$1.06M

Similar funds

Axa's Q1 2021 Portfolio in Review

As of Q1 2021, Axa held 1,396 positions worth $32.8B, up 3.1% from $31.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Axa's Q1 2021 filing shows 147 new, 409 increased, 509 reduced and 201 closed positions. Its largest new stake was Wynn Resorts: 347,770 shares worth $43.6M. The largest sale was Lemonade, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q1 2021 buy was Wynn Resorts: 347,770 shares worth $43.6M.
  • Axa added most to Stellantis in Q1 2021, an estimated $228M increase.
  • Axa's biggest Q1 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $84M.
  • Axa fully exited Lemonade in Q1 2021, selling an estimated $189M.
  • Axa's ten largest holdings make up 18% of its $32.8B portfolio in Q1 2021.
  • Axa opened 147 new positions and closed 201 in Q1 2021.
  • Axa's portfolio value rose 3.1% quarter-over-quarter to $32.8B.

Based on Axa's 13F filing for Q1 2021, filed 14 May 2021.